Outcomes of subsequent pregnancy following intrahepatic cholestasis of pregnancy: A retrospective cohort study
International Journal of Gynecology & Obstetrics · 16.07.2026
DOI: 10.1002/ijgo.71192 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 16.07.2026. Verfasst von Keren Zloto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel School of Medicine, Faculty of Medical and Health Sciences, Tel-A…. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Objective
Data on subsequent pregnancies after intrahepatic cholestasis of pregnancy (IHCP) are limited. We aimed to determine IHCP recurrence, identify risk factors, and describe outcomes in subsequent pregnancies.
Methods
This retrospective study at a tertiary center (2012–2024) included individuals with prior IHCP. Multiple gestations and those without a documented subsequent pregnancy were excluded. We assessed recurrence, maternal and neonatal outcomes, and compared characteristics between those with recurrent IHCP (rIHCP) and those without. Multivariable regression estimated odds ratios (OR) and 95% confidence intervals (CI).
Results
Among 142 087 deliveries, 1094 (0.8%) were diagnosed with IHCP, and 874 (80%) were singleton pregnancies. Of these, 264 (30.2%) had a subsequent pregnancy. IHCP recurred in 93/264 (35.2%). Individuals with rIHCP were younger (28 vs. 30.6 years, P < 0.01), more likely to undergo labor induction (79.6% vs. 66.7%, P = 0.02), and less likely to have cesarean delivery (7.5% vs. 22.2%, P < 0.01). Assisted reproductive techniques (ART) in the index pregnancy was associated with reduced recurrence (OR 0.3, 95% CI: 0.1–0.9), whereas earlier IHCP onset (35.1 vs. 35.5 weeks, OR 0.9, 95% CI: 0.8–0.9) and elevated liver enzymes (75.3% vs. 58.5%, OR 2.5, 95% CI: 1.4–4.6) increased recurrence risk. In subsequent pregnancies, rIHCP was associated with earlier delivery (37.3 vs. 39 weeks, P < 0.01), more labor induction (63.4% vs. 29.8%, P < 0.01), and lower cesarean rates (14% vs. 24.6%, P = 0.04).
Conclusion
Approximately one‐third of individuals with IHCP experience recurrence. Earlier onset, elevated liver enzymes, and lower ART use in the index pregnancy predict recurrence, providing critical information for counseling, clinical management, and future guideline development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Delaware Center of Maternal-Fetal Medicine at Christiana Care, Newark, Delaware, USA.
ORCID-Profile: Keren Zloto
Zitieren
APA
Zloto, K., Bartal, M. F., Tsur, A., Mazaki-Tovi, S., Yoeli-Ullman, R., Ofir, K., Bar-Adon, S., Chauhan, S., Sibai, B. M., & Dori-Dayan, N. (2026). Outcomes of subsequent pregnancy following intrahepatic cholestasis of pregnancy: A retrospective cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.71192
Vancouver
Zloto K, Bartal MF, Tsur A, Mazaki-Tovi S, Yoeli-Ullman R, Ofir K, et al. Outcomes of subsequent pregnancy following intrahepatic cholestasis of pregnancy: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.71192
BibTeX
@article{Zloto2026,
author = {Zloto, Keren and Bartal, Michal Fishel and Tsur, Abraham and Mazaki-Tovi, Shali and Yoeli-Ullman, Rakefet and Ofir, Keren and Bar-Adon, Sonya and Chauhan, Suneet and Sibai, Baha M and Dori-Dayan, Nimrod},
title = {Outcomes of subsequent pregnancy following intrahepatic cholestasis of pregnancy: A retrospective cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.71192}
}
EUVIMED